About this Journal Submit a Manuscript Table of Contents
Journal of Biomedicine and Biotechnology
Volume 2010 (2010), Article ID 740403, 17 pages
http://dx.doi.org/10.1155/2010/740403
Review Article

Biological Role of Dystroglycan in Schwann Cell Function and Its Implications in Peripheral Nervous System Diseases

1Centre for Neuroregeneration, University of Edinburgh, Chancellor's Building, 49 Little France Crescent, Edinburgh EH16 4SB, UK
2Faculty of Medical Sciences, Teikyo University of Science, 2-2 Senju-Sakuragi, Adachi-ku, Tokyo 120-0045, Japan
3Department of Neurology and Neuroscience, Teikyo University, 2-11-1 Kaga, Itabashi-ku, Tokyo 173-8605, Japan

Received 22 October 2009; Accepted 20 April 2010

Academic Editor: Chung-Liang Chien

Copyright © 2010 Toshihiro Masaki and Kiichiro Matsumura. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. M. Ervasti and K. P. Campbell, “Membrane organization of the dystrophin-glycoprotein complex,” Cell, vol. 66, no. 6, pp. 1121–1131, 1991. View at Scopus
  2. O. Ibraghimov-Beskrovnaya, J. M. Ervasti, C. J. Leveille, C. A. Slaughter, S. W. Sernett, and K. P. Campbell, “Primary structure of dystrophin-associated glycoproteins linking dystrophin to the extracellular matrix,” Nature, vol. 355, no. 6362, pp. 696–702, 1992. View at Publisher · View at Google Scholar · View at Scopus
  3. B. J. Petrof, J. B. Shrager, H. H. Stedman, A. M. Kelly, and H. L. Sweeney, “Dystrophin protects the sarcolemma from stresses developed during muscle contraction,” Proceedings of the National Academy of Sciences of the United States of America, vol. 90, no. 8, pp. 3710–3714, 1993. View at Scopus
  4. R. Barresi and K. P. Campbell, “Dystroglycan: from biosynthesis to pathogenesis of human disease,” Journal of Cell Science, vol. 119, no. 2, pp. 199–207, 2006. View at Publisher · View at Google Scholar · View at Scopus
  5. R. A. Williamson, M. D. Henry, K. J. Daniels et al., “Dystroglycan is essential for early embryonic development: disruption of Reichert's membrane in Dag1-null mice,” Human Molecular Genetics, vol. 6, no. 6, pp. 831–841, 1997. View at Publisher · View at Google Scholar · View at Scopus
  6. M. Durbeej, E. Larsson, O. Ibraghimov-Beskrovnaya, S. L. Roberds, K. P. Campbell, and P. Ekblom, “Non-muscle α-dystroglycan is involved in epithelial development,” Journal of Cell Biology, vol. 130, no. 1, pp. 79–91, 1995. View at Publisher · View at Google Scholar · View at Scopus
  7. M. Hidalgo, C. Sirour, V. Bello, N. Moreau, M. Beaudry, and T. Darribère, “In vivo analyzes of dystroglycan function during somitogenesis in Xenopus laevis,” Developmental Dynamics, vol. 238, no. 6, pp. 1332–1345, 2009. View at Publisher · View at Google Scholar · View at Scopus
  8. S. Li, D. Edgar, R. Fässler, W. Wadsworth, and P. D. Yurchenco, “The role of laminin in embryonic cell polarization and tissue organization,” Developmental Cell, vol. 4, no. 5, pp. 613–624, 2003. View at Publisher · View at Google Scholar · View at Scopus
  9. W.-M. Deng, M. Schneider, R. Frock et al., “Dystroglycan is required for polarizing the epithelial cells and the oocyte in Drosophila,” Development, vol. 130, no. 1, pp. 173–184, 2003. View at Publisher · View at Google Scholar · View at Scopus
  10. M. Masuda-Hirata, A. Suzuki, Y. Amano et al., “Intracellular polarity protein PAR-1 regulates extracellular laminin assembly by regulating the dystroglycan complex,” Genes to Cells, vol. 14, no. 7, pp. 835–850, 2009. View at Publisher · View at Google Scholar · View at Scopus
  11. M. D. Henry, M. B. Cohen, and K. P. Campbell, “Reduced expression of dystroglycan in breast and prostate cancer,” Human Pathology, vol. 32, no. 8, pp. 791–795, 2001. View at Publisher · View at Google Scholar · View at Scopus
  12. A. Sgambato and A. Brancaccio, “The dystroglycan complex: from biology to cancer,” Journal of Cellular Physiology, vol. 205, no. 2, pp. 163–169, 2005. View at Publisher · View at Google Scholar · View at Scopus
  13. W. Cao, M. D. Henry, P. Borrow et al., “Identification of α-dystroglycan as a receptor for lymphocytic choriomeningitis virus and Lassa fever virus,” Science, vol. 282, no. 5396, pp. 2079–2081, 1998. View at Publisher · View at Google Scholar · View at Scopus
  14. A. Rambukkana, H. Yamada, G. Zanazzi et al., “Role of α-dystroglycan as a Schwann cell receptor for Mycobacterium leprae,” Science, vol. 282, no. 5396, pp. 2076–2079, 1998. View at Publisher · View at Google Scholar · View at Scopus
  15. A. Rambukkana, S. Kunz, J. Min, K. P. Campbell, and M. B. A. Oldstone, “Targeting Schwann cells by nonlytic arenaviral infection selectively inhibits myelination,” Proceedings of the National Academy of Sciences of the United States of America, vol. 100, no. 26, pp. 16071–16076, 2003. View at Publisher · View at Google Scholar · View at Scopus
  16. S. A. Moore, F. Saito, J. Chen et al., “Deletion of brain dystroglycan recapitulates aspects of congenital muscular dystrophy,” Nature, vol. 418, no. 6896, pp. 422–425, 2002. View at Publisher · View at Google Scholar · View at Scopus
  17. J. E. Schröder, M. R. Tegeler, U. Großhans et al., “Dystroglycan regulates structure, proliferation and differentiation of neuroepithelial cells in the developing vertebrate CNS,” Developmental Biology, vol. 307, no. 1, pp. 62–78, 2007. View at Publisher · View at Google Scholar · View at Scopus
  18. D. L. Sherman and P. J. Brophy, “Mechanisms of axon ensheathment and myelin growth,” Nature Reviews Neuroscience, vol. 6, no. 9, pp. 683–690, 2005. View at Publisher · View at Google Scholar · View at Scopus
  19. K. Matsumura, H. Yamada, T. Shimizu, and K. P. Campbell, “Differential expression of dystrophin, utrophin and dystrophin-associated proteins in peripheral nerve,” FEBS Letters, vol. 334, no. 3, pp. 281–285, 1993. View at Publisher · View at Google Scholar · View at Scopus
  20. T. J. Byers, H. G. W. Lidov, and L. M. Kunkel, “An alternative dystrophin transcript specific to peripheral nerve,” Nature Genetics, vol. 4, no. 1, pp. 77–81, 1993. View at Publisher · View at Google Scholar · View at Scopus
  21. H. Yamada, T. Shimizu, T. Tanaka, K. P. Campbell, and K. Matsumura, “Dystroglycan is a binding protein of laminin and merosin in peripheral nerve,” FEBS Letters, vol. 352, no. 1, pp. 49–53, 1994. View at Publisher · View at Google Scholar · View at Scopus
  22. H. Yamada, A. Chiba, T. Endo et al., “Characterization of dystroglycan-laminin interaction in peripheral nerve,” Journal of Neurochemistry, vol. 66, no. 4, pp. 1518–1524, 1996. View at Scopus
  23. H. Yamada, A. J. Denzer, H. Hori et al., “Dystroglycan is a dual receptor for agrin and laminin-2 in Schwann cell membrane,” Journal of Biological Chemistry, vol. 271, no. 38, pp. 23418–23423, 1996. View at Publisher · View at Google Scholar · View at Scopus
  24. F. Saito, T. Masaki, K. Kamakura et al., “Characterization of the transmembrane molecular architecture of the dystroglycan complex in Schwann cells,” Journal of Biological Chemistry, vol. 274, no. 12, pp. 8240–8246, 1999. View at Publisher · View at Google Scholar · View at Scopus
  25. F. Saito, S. A. Moore, R. Barresi et al., “Unique role of dystroglycan in peripheral nerve myelination, nodal structure, and sodium channel stabilization,” Neuron, vol. 38, no. 5, pp. 747–758, 2003. View at Publisher · View at Google Scholar · View at Scopus
  26. M. Imamura, K. Araishi, S. Noguchi, and E. Ozawa, “A sarcoglycan-dystroglycan complex anchors Dp116 and utrophin in the peripheral nervous system,” Human Molecular Genetics, vol. 9, no. 20, pp. 3091–3100, 2000. View at Scopus
  27. D. L. Sherman, C. Fabrizi, C. S. Gillespie, and P. J. Brophy, “Specific disruption of a Schwann cell dystrophin-related protein complex in a demyelinating neuropathy,” Neuron, vol. 30, no. 3, pp. 677–687, 2001. View at Publisher · View at Google Scholar · View at Scopus
  28. S. Occhi, D. Zambroni, U. Del Carro et al., “Both laminin and Schwann cell dystroglycan are necessary for proper clustering of sodium channels at nodes of Ranvier,” Journal of Neuroscience, vol. 25, no. 41, pp. 9418–9427, 2005. View at Publisher · View at Google Scholar · View at Scopus
  29. D. E. Albrecht, D. L. Sherman, P. J. Brophy, and S. C. Froehner, “The ABCA1 cholesterol transporter associates with one of two distinct dystrophin-based scaffolds in Schwann cells,” Glia, vol. 56, no. 6, pp. 611–618, 2008. View at Publisher · View at Google Scholar · View at Scopus
  30. T. Masaki, K. Matsumura, F. Saito et al., “Expression of dystroglycan and laminin-2 in peripheral nerve under axonal degeneration and regeneration,” Acta Neuropathologica, vol. 99, no. 3, pp. 289–295, 2000. View at Scopus
  31. T. Masaki, K. Matsumura, F. Saito et al., “Association of dystroglycan and laminin-2 coexpression with myelinogenesis in peripheral nerves,” Medical Electron Microscopy, vol. 36, no. 4, pp. 221–239, 2003. View at Publisher · View at Google Scholar · View at Scopus
  32. T. Masaki, K. Matsumura, A. Hirata et al., “Expression of dystroglycan complex in satellite cells of dorsal root ganglia,” Acta Neuropathologica, vol. 101, no. 2, pp. 174–178, 2001. View at Scopus
  33. K. H. Holt, R. H. Crosbie, D. P. Venzke, and K. P. Campbell, “Biosynthesis of dystroglycan: processing of a precursor propeptide,” FEBS Letters, vol. 468, no. 1, pp. 79–83, 2000. View at Publisher · View at Google Scholar · View at Scopus
  34. E. Hohenester, D. Tisi, J. F. Talts, and R. Timpl, “The crystal structure of a laminin G-like module reveals the molecular basis of α-dystroglycan binding to laminins, perlecan, and agrin,” Molecular Cell, vol. 4, no. 5, pp. 783–792, 1999. View at Scopus
  35. D. Tisi, J. F. Talts, R. Timpl, and E. Hohenester, “Structure of the C-terminal laminin G-like domain pair of the laminin α2 chain harbouring binding sites for α-dystroglycan and heparin,” The EMBO Journal, vol. 19, no. 7, pp. 1432–1440, 2000. View at Scopus
  36. J. F. Talts, T. Sasaki, N. Miosge et al., “Structural and functional analysis of the recombinant G domain of the laminin α4 chain and its proteolytic processing in tissues,” Journal of Biological Chemistry, vol. 275, no. 45, pp. 35192–35199, 2000. View at Publisher · View at Google Scholar · View at Scopus
  37. J. M. Ervasti and K. P. Campbell, “A role for the dystrophin-glycoprotein complex as a transmembrane linker between laminin and actin,” Journal of Cell Biology, vol. 122, no. 4, pp. 809–823, 1993. View at Scopus
  38. A. Chiba, K. Matsumura, H. Yamada et al., “Structures of sialylated O-linked oligosaccharides of bovine peripheral nerve α-dystroglycan. The role of a novel O-mannosyl-type oligosaccharide in the binding of α-dystroglycan with laminin,” Journal of Biological Chemistry, vol. 272, no. 4, pp. 2156–2162, 1997. View at Publisher · View at Google Scholar · View at Scopus
  39. A. C. Combs and J. M. Ervasti, “Enhanced laminin binding by α-dystroglycan after enzymatic deglycosylation,” Biochemical Journal, vol. 390, no. 1, pp. 303–309, 2005. View at Publisher · View at Google Scholar · View at Scopus
  40. H. Hall, D. Bozic, K. Michel, and J. A. Hubbell, “N-terminal α-dystroglycan binds to different extracellular matrix molecules expressed in regenerating peripheral nerves in a protein-mediated manner and promotes neurite extension of PC12 cells,” Molecular and Cellular Neuroscience, vol. 24, no. 4, pp. 1062–1073, 2003. View at Publisher · View at Google Scholar · View at Scopus
  41. W. Chung and J. T. Campanelli, “WW and EF hand domains of dystrophin-family proteins mediate dystroglycan binding,” Molecular Cell Biology Research Communications, vol. 2, no. 3, pp. 162–171, 1999. View at Scopus
  42. D. J. Blake and E. Martin-Rendon, “Intermediate filaments and the function of the dystrophin-protein complex,” Trends in Cardiovascular Medicine, vol. 12, no. 5, pp. 224–228, 2002. View at Publisher · View at Google Scholar · View at Scopus
  43. D. E. Albrecht and S. C. Froehner, “DAMAGE, a novel α-dystrobrevin-associated MAGE protein in dystrophin complexes,” Journal of Biological Chemistry, vol. 279, no. 8, pp. 7014–7023, 2004. View at Publisher · View at Google Scholar · View at Scopus
  44. Y.-J. Chen, H. J. Spence, J. M. Cameron, T. Jess, J. L. Ilsley, and S. J. Winder, “Direct interaction of β-dystroglycan with F-actin,” Biochemical Journal, vol. 375, no. 2, pp. 329–337, 2003. View at Publisher · View at Google Scholar · View at Scopus
  45. D. E. Albrecht and S. C. Froehner, “Syntrophins and dystrobrevins: defining the dystrophin scaffold at synapses,” NeuroSignals, vol. 11, no. 3, pp. 123–129, 2002. View at Publisher · View at Google Scholar · View at Scopus
  46. K. Hnia, G. Hugon, A. Masmoudi, J. Mercier, F. Rivier, and D. Mornet, “Effect of β-dystroglycan processing on utrophin/Dp116 anchorage in normal and mdx mouse Schwann cell membrane,” Neuroscience, vol. 141, no. 2, pp. 607–620, 2006. View at Publisher · View at Google Scholar · View at Scopus
  47. H. Yamada, F. Saito, H. Fukuta-Ohi et al., “Processing of β-dystroglycan by matrix metalloproteinase disrupts the link between the extracellular matrix and cell membrane via the dystroglycan complex,” Human Molecular Genetics, vol. 10, no. 15, pp. 1563–1569, 2001. View at Scopus
  48. K. Matsumura, D. Zhong, F. Saito et al., “Proteolysis of β-dystroglycan in muscular diseases,” Neuromuscular Disorders, vol. 15, no. 5, pp. 336–341, 2005. View at Publisher · View at Google Scholar · View at Scopus
  49. D. Zhong, F. Saito, Y. Saito, A. Nakamura, T. Shimizu, and K. Matsumura, “Characterization of the protease activity that cleaves the extracellular domain of β-dystroglycan,” Biochemical and Biophysical Research Communications, vol. 345, no. 2, pp. 867–871, 2006. View at Publisher · View at Google Scholar · View at Scopus
  50. H. Cai, R. A. Erdman, L. Zweier et al., “The sarcoglycan complex in Schwann cells and its role in myelin stability,” Experimental Neurology, vol. 205, no. 1, pp. 257–269, 2007. View at Publisher · View at Google Scholar · View at Scopus
  51. F. A. Court, D. L. Sherman, T. Pratt et al., “Restricted growth of Schwann cells lacking Cajal bands slows conduction in myelinated nerves,” Nature, vol. 431, no. 7005, pp. 191–195, 2004. View at Publisher · View at Google Scholar · View at Scopus
  52. F. A. Court, J. E. Hewitt, K. Davies et al., “A laminin-2, dystroglycan, utrophin axis is required for compartmentalization and elongation of myelin segments,” Journal of Neuroscience, vol. 29, no. 12, pp. 3908–3919, 2009. View at Publisher · View at Google Scholar · View at Scopus
  53. C. Salim, Y. V. Boxberg, J. Alterio, S. Féréol, and F. Nothias, “The giant protein AHNAK involved in morphogenesis and laminin substrate adhesion of myelinating Schwann cells,” Glia, vol. 57, no. 5, pp. 535–549, 2009. View at Publisher · View at Google Scholar · View at Scopus
  54. A. Nodari, S. C. Previtali, G. Dati et al., “α6 β4 integrin and dystroglycan cooperate to stabilize the myelin sheath,” Journal of Neuroscience, vol. 28, no. 26, pp. 6714–6719, 2008. View at Publisher · View at Google Scholar · View at Scopus
  55. A. M. Michelson, E. S. Russell, and P. J. Harman, “Dystrophia muscularis: a hereditary primary myopathy in the house mouse,” Proceedings of the National Academy of Sciences of the United States of America, vol. 41, no. 12, pp. 1079–1084, 1955.
  56. W. G. Bradley and M. Jenkison, “Neural abnormalities in the dystrophic mouse,” Journal of the Neurological Sciences, vol. 25, no. 2, pp. 249–255, 1975. View at Publisher · View at Google Scholar · View at Scopus
  57. W. G. Bradley, E. Jaros, and M. Jenkison, “The nodes of Ranvier in the nerves of mice with muscular dystrophy,” Journal of Neuropathology and Experimental Neurology, vol. 36, no. 5, pp. 797–806, 1977. View at Scopus
  58. C. A. Stirling, “Abnormalities in Schwann cell sheaths in spinal nerve roots of dystrophic mice,” Journal of Anatomy, vol. 119, no. 1, pp. 169–180, 1975. View at Scopus
  59. E. Jaros and W. G. Bradley, “Atypical axon-Schwann cell relationships in the common peroneal nerve of the dystrophic mouse: an ultrastructural study,” Neuropathology and Applied Neurobiology, vol. 5, no. 2, pp. 133–147, 1979. View at Scopus
  60. M. L. Feltri and L. Wrabetz, “Laminins and their receptors in Schwann cells and hereditary neuropathies,” Journal of the Peripheral Nervous System, vol. 10, no. 2, pp. 128–143, 2005. View at Publisher · View at Google Scholar · View at Scopus
  61. B. L. Patton, J. H. Miner, A. Y. Chiu, and J. R. Sanes, “Distribution and function of laminins in the neuromuscular system of developing, adult, and mutant mice,” Journal of Cell Biology, vol. 139, no. 6, pp. 1507–1521, 1997. View at Publisher · View at Google Scholar · View at Scopus
  62. B. L. Patton, B. Wang, Y. S. Tarumi, K. L. Seburn, and R. W. Burgess, “A single point mutation in the LN domain of LAMA2 causes muscular dystrophy and peripheral amyelination,” Journal of Cell Science, vol. 121, no. 10, pp. 1593–1604, 2008. View at Publisher · View at Google Scholar · View at Scopus
  63. H. Xu, X.-R. Wu, U. M. Wewer, and E. Engval, “Murine muscular dystrophy caused by a mutation in the laminin α2 (Lama2) gene,” Nature Genetics, vol. 8, no. 3, pp. 297–302, 1994. View at Publisher · View at Google Scholar · View at Scopus
  64. Y. Sunada, S. M. Bernier, A. Utani, Y. Yamada, and K. P. Campbell, “Identification of a novel mutant transcript of laminin α2 chain gene responsible for muscular dystrophy and dysmyelination in dy2J mice,” Human Molecular Genetics, vol. 4, no. 6, pp. 1055–1061, 1995. View at Scopus
  65. W.-M. Yu, Z.-L. Chen, A. J. North, and S. Strickland, “Laminin is required for Schwann cell morphogenesis,” Journal of Cell Science, vol. 122, no. 7, pp. 929–936, 2009. View at Publisher · View at Google Scholar · View at Scopus
  66. M. Nakagawa, Y. Miyagoe-Suzuki, K. Ikezoe, et al., “Schwann cell myelination occurred without basal lamina formation in laminin α2 chain-null mutant (dy3K/dy3K) mice,” Glia, vol. 35, no. 2, pp. 101–110, 2001.
  67. D. Yang, J. Bierman, Y. S. Tarumi et al., “Coordinate control of axon defasciculation and myelination by laminin-2 and-8,” Journal of Cell Biology, vol. 168, no. 4, pp. 655–666, 2005. View at Publisher · View at Google Scholar · View at Scopus
  68. Z.-L. Chen and S. Strickland, “Laminin γ1 is critical for Schwann cell differentiation, axon myelination, and regeneration in the peripheral nerve,” Journal of Cell Biology, vol. 163, no. 4, pp. 889–899, 2003. View at Publisher · View at Google Scholar · View at Scopus
  69. C. S. Gillespie, D. L. Sherman, S. M. Fleetwood-Walker et al., “Peripheral demyelination and neuropathic pain behavior in periaxin-deficient mice,” Neuron, vol. 26, no. 2, pp. 523–531, 2000. View at Scopus
  70. E. N. Levedakou, X.-J. Chen, B. Soliven, and B. Popko, “Disruption of the mouse Large gene in the enr and myd mutants results in nerve, muscle, and neuromuscular junction defects,” Molecular and Cellular Neuroscience, vol. 28, no. 4, pp. 757–769, 2005. View at Publisher · View at Google Scholar · View at Scopus
  71. F. Saito, T. Masaki, Y. Saito et al., “Defective peripheral nerve myelination and neuromuscular junction formation in fukutin-deficient chimeric mice,” Journal of Neurochemistry, vol. 101, no. 6, pp. 1712–1722, 2007. View at Publisher · View at Google Scholar · View at Scopus
  72. M. L. Feltri, D. G. Porta, S. C. Previtali et al., “Conditional disruption of β1 integrin in Schwann cells impedes interactions with axons,” Journal of Cell Biology, vol. 156, no. 1, pp. 199–209, 2002. View at Publisher · View at Google Scholar · View at Scopus
  73. W. Kuang, H. Xu, P. H. Vachon et al., “Merosin-deficient congenital muscular dystrophy: partial genetic correction in two mouse models,” Journal of Clinical Investigation, vol. 102, no. 4, pp. 844–852, 1998. View at Scopus
  74. S. C. Previtali, A. Nodari, C. Taveggia et al., “Expression of laminin receptors in Schwann cell differentiation: evidence for distinct roles,” Journal of Neuroscience, vol. 23, no. 13, pp. 5520–5530, 2003. View at Scopus
  75. K. I. Gawlik, J.-Y. Li, A. Petersén, and M. Durbeej, “Laminin α1 chain improves laminin α2 chain deficient peripheral neuropathy,” Human Molecular Genetics, vol. 15, no. 18, pp. 2690–2700, 2006. View at Publisher · View at Google Scholar · View at Scopus
  76. S. Einheber, T. A. Milner, F. Giancotti, and J. L. Salzer, “Axonal regulation of Schwann cell integrin expression suggests a role for α6β4 in myelination,” Journal of Cell Biology, vol. 123, no. 5, pp. 1223–1236, 1993. View at Publisher · View at Google Scholar · View at Scopus
  77. C. Fernandez-Valle, L. Gwynn, P. M. Wood, S. Carbonetto, and M. B. Bunge, “Anti-β1 integrin antibody inhibits Schwann cell myelination,” Journal of Neurobiology, vol. 25, no. 10, pp. 1207–1226, 1994. View at Scopus
  78. M. L. Feltri, S. S. Scherer, R. Nemni et al., “β4 integrin expression in myelinating Schwann cells is polarized, developmentally regulated and axonally dependent,” Development, vol. 120, no. 5, pp. 1287–1301, 1994. View at Scopus
  79. D. E. Michele, R. Barresi, M. Kanagawa et al., “Post-translational disruption of dystroglycan-ligand interactions in congenital muscular dystrophies,” Nature, vol. 418, no. 6896, pp. 417–422, 2002. View at Publisher · View at Google Scholar · View at Scopus
  80. D.-S. Kim, Y. K. Hayashi, H. Matsumoto et al., “POMT1 mutation results in defective glycosylation and loss of laminin-binding activity in α-DG,” Neurology, vol. 62, no. 6, pp. 1009–1011, 2004. View at Scopus
  81. T. Toda, K. Kobayashi, S. Takeda et al., “Fukuyama-type congenital muscular dystrophy (FCMD) and alpha-dystroglycanopathy,” Congenital Anomalies, vol. 43, no. 2, pp. 97–104, 2003. View at Scopus
  82. T. Toda, T. Chiyonobu, H. Xiong et al., “Fukutin and α-dystroglycanopahties,” Acta Myologica, vol. 24, no. 2, pp. 60–63, 2005. View at Scopus
  83. E. Mercuri, S. Messina, C. Bruno et al., “Congenital muscular dystrophies with defective glycosylation of dystroglycan: a population study,” Neurology, vol. 72, no. 21, pp. 1802–1809, 2009. View at Publisher · View at Google Scholar · View at Scopus
  84. R. P. Bunge, M. B. Bunge, and C. F. Eldridge, “Linkage between axonal ensheathment and basal lamina production by Schwann cells,” Annual Review of Neuroscience, vol. 9, pp. 305–328, 1986. View at Scopus
  85. C. F. Eldridge, M. B. Bunge, and R. P. Bunge, “Differentiation of axon-related Schwann cells in vitro: II. Control of myelin formation by basal lamina,” Journal of Neuroscience, vol. 9, no. 2, pp. 625–638, 1989. View at Scopus
  86. K. Matsumura, H. Yamada, F. Saito, Y. Sunada, and T. Shimizu, “Peripheral nerve involvement in merosin-deficient congenital muscular dystrophy and dy mouse,” Neuromuscular Disorders, vol. 7, no. 1, pp. 7–12, 1997. View at Publisher · View at Google Scholar · View at Scopus
  87. T. Masaki, K. Matsumura, A. Hirata et al., “Expression of dystroglycan and the laminin-α2 chain in the rat peripheral nerve during development,” Experimental Neurology, vol. 174, no. 1, pp. 109–117, 2002. View at Publisher · View at Google Scholar · View at Scopus
  88. A. Rambukkana, J. L. Salzer, P. D. Yurchenco, and E. I. Tuomanen, “Neural targeting of Mycobacterium leprae mediated by the G domain of the laminin-α2 chain,” Cell, vol. 88, no. 6, pp. 811–821, 1997. View at Publisher · View at Google Scholar · View at Scopus
  89. S. Kunz, N. Sevilla, D. B. McGavern, K. P. Campbell, and M. B. A. Oldstone, “Molecular analysis of the interaction of LCMV with its cellular receptor α-dystroglycan,” Journal of Cell Biology, vol. 155, no. 2, pp. 301–310, 2001. View at Publisher · View at Google Scholar · View at Scopus
  90. S. Kunz, J. M. Rojek, M. Perez, C. F. Spiropoulou, and M. B. A. Oldstone, “Characterization of the interaction of lassa fever virus with its cellular receptor α-dystroglycan,” Journal of Virology, vol. 79, no. 10, pp. 5979–5987, 2005. View at Publisher · View at Google Scholar · View at Scopus
  91. A. Rambukkana, G. Zanazzi, N. Tapinos, and J. L. Salzer, “Contact-dependent demyelination by Mycobacterium leprae in the absence of immune cells,” Science, vol. 296, no. 5569, pp. 927–931, 2002. View at Publisher · View at Google Scholar · View at Scopus
  92. N. Tapinos, M. Ohnishi, and A. Rambukkana, “ErbB2 receptor tyrosine kinase signaling mediates early demyelination induced by leprosy bacilli,” Nature Medicine, vol. 12, no. 8, pp. 961–966, 2006. View at Publisher · View at Google Scholar · View at Scopus
  93. H. Colognato, J. Galvin, Z. Wang et al., “Identification of dystroglycan as a second laminin receptor in oligodendrocytes, with a role in myelination,” Development, vol. 134, no. 9, pp. 1723–1736, 2007. View at Publisher · View at Google Scholar · View at Scopus
  94. Y. Miyagoe-Suzuki, M. Nakagawa, and S. Takeda, “Merosin and congenital muscular dystrophy,” Microscopy Research and Technique, vol. 48, no. 3-4, pp. 181–191, 2000. View at Scopus
  95. S. J. Chun, M. N. Rasband, R. L. Sidman, A. A. Habib, and T. Vartanian, “Integrin-linked kinase is required for laminin-2-induced oligodendrocyte cell spreading and CNS myelination,” Journal of Cell Biology, vol. 163, no. 2, pp. 397–408, 2003. View at Publisher · View at Google Scholar · View at Scopus
  96. R. P. Bunge, M. B. Bunge, and M. Bates, “Movements of the Schwann cell nucleus implicate progression of the inner (axon-related) Schwann cell process during myelination,” Journal of Cell Biology, vol. 109, no. 1, pp. 273–284, 1989. View at Scopus
  97. R. Han, M. Kanagawa, T. Yoshida-Moriguchi et al., “Basal lamina strengthens cell membrane integrity via the laminin G domain-binding motif of α-dystroglycan,” Proceedings of the National Academy of Sciences of the United States of America, vol. 106, no. 31, pp. 12573–12579, 2009. View at Publisher · View at Google Scholar · View at Scopus
  98. K. Matsumura, A. Chiba, H. Yamada et al., “A role of dystroglycan in schwannoma cell adhesion to laminin,” Journal of Biological Chemistry, vol. 272, no. 21, pp. 13904–13910, 1997. View at Publisher · View at Google Scholar · View at Scopus
  99. J. L. Podratz, E. Rodriguez, and A. J. Windebank, “Role of the extracellular matrix in myelination of peripheral nerve,” Glia, vol. 35, no. 1, pp. 35–40, 2001. View at Publisher · View at Google Scholar · View at Scopus
  100. M. A. Chernousov, W. M. Yu, Z. L. Chen, D. J. Carey, and S. Strickland, “Regulation of Schwann cell function by the extracellular matrix,” Glia, vol. 56, no. 14, pp. 1498–1507, 2008. View at Scopus
  101. M. James, A. Nuttall, J. L. Ilsley et al., “Adhesion-dependent tyrosine phosphorylation of β-dystroglycan regulates its interaction with utrophin,” Journal of Cell Science, vol. 113, no. 10, pp. 1717–1726, 2000. View at Scopus
  102. J. L. Ilsley, M. Sudol, and S. J. Winder, “The interaction of dystrophin with β-dystroglycan is regulated by tyrosine phosphorylation,” Cellular Signalling, vol. 13, no. 9, pp. 625–632, 2001. View at Publisher · View at Google Scholar · View at Scopus
  103. B. Yang, D. Jung, D. Motto, J. Meyer, G. Koretzky, and K. P. Campbell, “SH3 domain-mediated interaction of dystroglycan and Grb2,” Journal of Biological Chemistry, vol. 270, no. 20, pp. 11711–11714, 1995. View at Publisher · View at Google Scholar · View at Scopus
  104. M. Cavaldesi, G. Macchia, S. Barca, P. Defilippi, G. Tarone, and T. C. Petrucci, “Association of the dystroglycan complex isolated from bovine brain synaptosomes with proteins involved in signal transduction,” Journal of Neurochemistry, vol. 72, no. 4, pp. 1648–1655, 1999. View at Publisher · View at Google Scholar · View at Scopus
  105. K. Russo, E. Di Stasio, G. Macchia, G. Rosa, A. Brancaccio, and T. C. Petrucci, “Characterization of the β-dystroglycan-growth factor receptor 2 (Grb2) interaction,” Biochemical and Biophysical Research Communications, vol. 274, no. 1, pp. 93–98, 2000. View at Publisher · View at Google Scholar · View at Scopus
  106. F. Sotgia, H. Lee, M. T. Bedford, T. Petrucci, M. Sudol, and M. P. Lisanti, “Tyrosine phosphorylation of β-dystroglycan at its WW domain binding motif, PPxY, recruits SH2 domain containing proteins,” Biochemistry, vol. 40, no. 48, pp. 14585–14592, 2001. View at Publisher · View at Google Scholar · View at Scopus
  107. H. J. Spence, A. S. Dhillon, M. James, and S. Winder, “Dystroglycan, a scaffold for the ERK-MAP kinase cascade,” EMBO Reports, vol. 5, no. 5, pp. 484–489, 2004. View at Publisher · View at Google Scholar · View at Scopus
  108. C. L. Batchelor and S. J. Winder, “Sparks, signals and shock absorbers: how dystrophin loss causes muscular dystrophy,” Trends in Cell Biology, vol. 16, no. 4, pp. 198–205, 2006. View at Publisher · View at Google Scholar · View at Scopus
  109. C. L. Batchelor, J. R. Higginson, Y.-J. Chen, C. Vanni, A. Eva, and S. J. Winder, “Recruitment of Dbl by ezrin and dystroglycan drives membrane proximal Cdc42 activation and filopodia formation,” Cell Cycle, vol. 6, no. 3, pp. 353–363, 2007. View at Scopus
  110. N. P. J. Vogtländer, H. J. Visch, M. A. H. Bakker, J. H. M. Berden, and J. van der Vlag, “Ligation of α-dystroglycan on podocytes induces intracellular signaling: a new mechanism for podocyte effacement?” PLoS ONE, vol. 4, no. 6, article e5979, 2009. View at Publisher · View at Google Scholar · View at Scopus
  111. Y. W. Zhou, S. A. Oak, S. E. Senogles, and H. W. Jarrett, “Laminin-alpha1 globular domains 3 and 4 induce heterotrimeric G protein binding to alpha-syntrophin's PDZ domain and alter intracellular Ca2+ in muscle,” American Journal of Physiology, vol. 288, no. 2, pp. C377–C388, 2005. View at Scopus
  112. K. J. Langenbach and T. A. Rando, “Inhibition of dystroglycan binding to laminin disrupts the PI3K/AKT pathway and survival signaling in muscle cells,” Muscle and Nerve, vol. 26, no. 5, pp. 644–653, 2002. View at Publisher · View at Google Scholar · View at Scopus
  113. Y. Zhou, D. Jiang, D. B. Thomason, and H. W. Jarrett, “Laminin-induced activation of Rac1 and JNKp46 is initiated by Src family kinases and mimics the effects of skeletal muscle contraction,” Biochemistry, vol. 46, no. 51, pp. 14907–14916, 2007. View at Publisher · View at Google Scholar · View at Scopus
  114. Y. Xiong, Y. Zhou, and H. W. Jarrett, “Dystrophin glycoprotein complex-associated Gβγ subunits activate phosphatidylinositol-3-kinase/akt signaling in skeletal muscle in a laminin-dependent manner,” Journal of Cellular Physiology, vol. 219, no. 2, pp. 402–414, 2009. View at Publisher · View at Google Scholar · View at Scopus
  115. S. A. Oak, Y. W. Zhou, and H. W. Jarrett, “Skeletal muscle signaling pathway through the dystrophin glycoprotein complex and Rac1,” Journal of Biological Chemistry, vol. 278, no. 41, pp. 39287–39295, 2003. View at Publisher · View at Google Scholar · View at Scopus
  116. M. M. Kucherenko, M. Pantoja, A. S. Yatsenko et al., “Genetic modifier screens reveal new components that interact with the Drosophila dystroglycan-dystrophin complex,” PLoS ONE, vol. 3, no. 6, article e2418, 2008. View at Publisher · View at Google Scholar · View at Scopus
  117. S. Li, P. Liquari, K. K. McKee et al., “Laminin-sulfatide binding initiates basement membrane assembly and enables receptor signaling in Schwann cells and fibroblasts,” Journal of Cell Biology, vol. 169, no. 1, pp. 179–189, 2005. View at Publisher · View at Google Scholar · View at Scopus
  118. P. Guicheney, N. Vignier, A. Helbling-Leclerc et al., “Genetics of laminin α2 chain (or merosin) deficient congenital muscular dystrophy: from identification of mutations to prenatal diagnosis,” Neuromuscular Disorders, vol. 7, no. 3, pp. 180–186, 1997. View at Publisher · View at Google Scholar · View at Scopus
  119. Z. Shorer, J. Philpot, F. Muntoni, C. Sewry, and V. Dubowitz, “Demyelinating peripheral neuropathy in merosin-deficient congenital muscular dystrophy,” Journal of Child Neurology, vol. 10, no. 6, pp. 472–475, 1995. View at Scopus
  120. M. Mora, I. Moroni, G. Uziel et al., “Mild clinical phenotype in a 12-year-old boy with partial merosin deficiency and central and peripheral nervous system abnormalities,” Neuromuscular Disorders, vol. 6, no. 5, pp. 377–381, 1996. View at Publisher · View at Google Scholar · View at Scopus
  121. A. Di Muzio, M. V. De Angelis, P. Di Fulvio et al., “Dysmyelinating sensory-motor neuropathy in merosin-deficient congenital muscular dystrophy,” Muscle and Nerve, vol. 27, no. 4, pp. 500–506, 2003. View at Publisher · View at Google Scholar · View at Scopus
  122. S. Quijano-Roy, F. Renault, N. Romero, P. Guicheney, M. Fardeau, and B. Estournet, “EMG and nerve conduction studies in children with congenital muscular dystrophy,” Muscle and Nerve, vol. 29, no. 2, pp. 292–299, 2004. View at Publisher · View at Google Scholar · View at Scopus
  123. Y. K. R. Habeeb, M. Al-Bloushi, E. S. Al-Jumah, T. M. De Souza, and A. Moosa, “Congenital muscular dystrophy in Arab children,” Journal of Child Neurology, vol. 21, no. 5, pp. 400–405, 2006. View at Publisher · View at Google Scholar · View at Scopus
  124. F. Deodato, M. Sabatelli, E. Ricci et al., “Hypermyelinating neuropathy, mental retardation and epilepsy in a case of merosin deficiency,” Neuromuscular Disorders, vol. 12, no. 4, pp. 392–398, 2002. View at Publisher · View at Google Scholar · View at Scopus
  125. M. Vainzof, S. K. N. Marie, U. C. Reed et al., “Deficiency of merosin (laminin M or α2) in congenital muscular dystrophy associated with cerebral white matter alterations,” Neuropediatrics, vol. 26, no. 6, pp. 293–297, 1995. View at Scopus
  126. C. P. Trevisan, F. Martinello, E. Ferruzza, M. Fanin, M. Chevallay, and F. M. S. Tomé, “Brain alterations in the classical form of congenital muscular dystrophy. Clinical and neuroimaging follow-up of 12 cases and correlation with the expression of merosin in muscle,” Child's Nervous System, vol. 12, no. 10, pp. 604–610, 1996. View at Scopus
  127. T. Haenggi and J.-M. Fritschy, “Role of dystrophin and utrophin for assembly and function of the dystrophin glycoprotein complex in non-muscle tissue,” Cellular and Molecular Life Sciences, vol. 63, no. 14, pp. 1614–1631, 2006. View at Publisher · View at Google Scholar · View at Scopus
  128. F. Muntoni, S. Torelli, and M. Brockington, “Muscular dystrophies due to glycosylation defects,” Neurotherapeutics, vol. 5, no. 4, pp. 627–632, 2008. View at Publisher · View at Google Scholar · View at Scopus
  129. T. Yamamoto, Y. Kato, M. Kawaguchi-Niida et al., “Characteristics of neurons and glia in the brain of Fukuyama type congenital muscular dystrophy,” Acta Myologica, vol. 27, pp. 9–13, 2008. View at Scopus
  130. A. Waite, C. L. Tinsley, M. Locke, and D. J. Blake, “The neurobiology of the dystrophin-associated glycoprotein complex,” Annals of Medicine, vol. 41, no. 5, pp. 344–359, 2009. View at Publisher · View at Google Scholar · View at Scopus
  131. V. Delague, C. Bareil, S. Tuffery et al., “Mapping of a new locus for autosomal recessive demyelinating charcot- marie-tooth disease to 19q13.1-13.3 in a large consanguineous Lebanese family: exclusion of MAG as a candidate gene,” American Journal of Human Genetics, vol. 67, no. 1, pp. 236–243, 2000. View at Publisher · View at Google Scholar · View at Scopus
  132. C. F. Boerkoel, H. Takashima, P. Stankiewicz et al., “Periaxin mutations cause recessive dejerine-sottas neuropathy,” American Journal of Human Genetics, vol. 68, no. 2, pp. 325–333, 2001. View at Publisher · View at Google Scholar · View at Scopus
  133. A. Guilbot, A. Williams, N. Ravisé et al., “A mutation in periaxin is responsible for CMT4F, an autosomal recessive form of Charcot-Marie-Tooth disease,” Human Molecular Genetics, vol. 10, no. 4, pp. 415–421, 2001. View at Scopus
  134. H. Takashima, C. F. Boerkoel, P. De Jonghe et al., “Periaxin mutations cause a broad spectrum of demyelinating neuropathies,” Annals of Neurology, vol. 51, no. 6, pp. 709–715, 2002. View at Publisher · View at Google Scholar · View at Scopus
  135. K. R. Jessen and R. Mirsky, “Negative regulation of myelination: relevance for development, injury, and demyelinating disease,” Glia, vol. 56, no. 14, pp. 1552–1565, 2008. View at Scopus
  136. R. Mirsky, A. Woodhoo, D. B. Parkinson, P. Arthur-Farraj, A. Bhaskaran, and K. R. Jessen, “Novel signals controlling embryonic Schwann cell development, myelination and dedifferentiation,” Journal of the Peripheral Nervous System, vol. 13, no. 2, pp. 122–135, 2008. View at Publisher · View at Google Scholar · View at Scopus
  137. X. Chen, H. Xu, P. Yuan et al., “Integration of external signaling pathways with the core transcriptional network in embryonic stem cells,” Cell, vol. 133, no. 6, pp. 1106–1117, 2008. View at Publisher · View at Google Scholar · View at Scopus
  138. F.-J. Müller, L. C. Laurent, D. Kostka et al., “Regulatory networks define phenotypic classes of human stem cell lines,” Nature, vol. 455, no. 7211, pp. 401–405, 2008. View at Publisher · View at Google Scholar · View at Scopus
  139. M. Gstaiger and R. Aebersold, “Applying mass spectrometry-based proteomics to genetics, genomics and network biology,” Nature Reviews Genetics, vol. 10, no. 9, pp. 617–627, 2009. View at Publisher · View at Google Scholar · View at Scopus
  140. J. L. Salzer, “Polarized domains of myelinated axons,” Neuron, vol. 40, no. 2, pp. 297–318, 2003. View at Publisher · View at Google Scholar · View at Scopus
  141. J. L. Salzer, P. J. Brophy, and E. Peles, “Molecular domains of myelinated axons in the peripheral nervous system,” Glia, vol. 56, no. 14, pp. 1532–1540, 2008. View at Scopus
  142. M. A. Bowe, D. B. Mendis, and J. R. Fallon, “The small leucine-rich repeat proteoglycan biglycan binds to α-dystroglycan and is upregulated in dystrophic muscle,” Journal of Cell Biology, vol. 148, no. 4, pp. 801–810, 2000. View at Publisher · View at Google Scholar · View at Scopus
  143. J. F. Talts, Z. Andac, W. Göhring, A. Brancaccio, and R. Timpl, “Binding of the G domains of laminin α1 and α2 chains and perlecan to heparin, sulfatides, α-dystroglycan and several extracellular matrix proteins,” The EMBO Journal, vol. 18, no. 4, pp. 863–870, 1999. View at Publisher · View at Google Scholar · View at Scopus
  144. M. D. Henry, J. S. Satz, C. Brakebusch et al., “Distinct roles for dystroglycan, β1 integrin and perlecan in cell surface laminin organization,” Journal of Cell Science, vol. 114, no. 6, pp. 1137–1144, 2001. View at Scopus
  145. V. Mirouse, C. P. Christoforou, C. Fritsch, D. St. Johnston, and R. P. Ray, “Dystroglycan and perlecan provide a basal cue required for epithelial polarity during energetic stress,” Developmental Cell, vol. 16, no. 1, pp. 83–92, 2009. View at Publisher · View at Google Scholar · View at Scopus
  146. S. Sato, Y. Omori, K. Katoh et al., “Pikachurin, a dystroglycan ligand, is essential for photoreceptor ribbon synapse formation,” Nature Neuroscience, vol. 11, no. 8, pp. 923–931, 2008. View at Publisher · View at Google Scholar · View at Scopus
  147. P. D. Côté, H. Moukhles, and S. Carbonetto, “Dystroglycan is not required for localization of dystrophin, syntrophin, and neuronal nitric-oxide synthase at the sarcolemma but regulates integrin α7B expression and caveolin-3 distribution,” Journal of Biological Chemistry, vol. 277, no. 7, pp. 4672–4679, 2002. View at Publisher · View at Google Scholar · View at Scopus
  148. A. Driss, L. Charrier, Y. Yan, V. Nduati, S. Sitaraman, and D. Merlin, “Dystroglycan receptor is involved in integrin activation in intestinal epithelia,” American Journal of Physiology, vol. 290, no. 6, pp. G1228–G1242, 2006. View at Publisher · View at Google Scholar · View at Scopus
  149. E. Guadagno and H. Moukhles, “Laminin-induced aggregation of the inwardly rectifying potassium channel, Kir4.1, and the water-permeable channel, AQP4, via a dystroglycan-containing complex in astrocytes,” Glia, vol. 47, no. 2, pp. 138–149, 2004. View at Publisher · View at Google Scholar · View at Scopus
  150. G. P. Nicchia, L. Cogotzi, A. Rossi, et al., “Expression of multiple AQP4 pools in the plasma membrane and their association with the dystrophin complex,” Journal of Neurochemistry, vol. 105, no. 6, pp. 2156–2165, 2008. View at Publisher · View at Google Scholar · View at Scopus
  151. E. Ambrosini, B. Serafini, A. Lanciotti et al., “Biochemical characterization of MLC1 protein in astrocytes and its association with the dystrophin-glycoprotein complex,” Molecular and Cellular Neuroscience, vol. 37, no. 3, pp. 480–493, 2008. View at Publisher · View at Google Scholar · View at Scopus
  152. D. J. Blake, A. Weir, S. E. Newey, and K. E. Davies, “Function and genetics of dystrophin and dystrophin-related proteins in muscle,” Physiological Reviews, vol. 82, no. 2, pp. 291–329, 2002. View at Scopus
  153. Y. Eshed, K. Feinberg, S. Poliak et al., “Gliomedin mediates Schwann cell-axon interaction and the molecular assembly of the nodes of Ranvier,” Neuron, vol. 47, no. 2, pp. 215–229, 2005. View at Publisher · View at Google Scholar · View at Scopus
  154. G. Noël, M. Belda, E. Guadagno, J. Micoud, N. Klöcker, and H. Moukhles, “Dystroglycan and Kir4.1 coclustering in retinal Müller glia is regulated by laminin-1 and requires the PDZ-ligand domain of Kir4.1,” Journal of Neurochemistry, vol. 94, no. 3, pp. 691–702, 2005. View at Publisher · View at Google Scholar · View at Scopus
  155. K. W. Prins, J. L. Humston, A. Mehta, V. Tate, E. Ralston, and J. M. Ervasti, “Dystrophin is a microtubule-associated protein,” Journal of Cell Biology, vol. 186, no. 3, pp. 363–369, 2009. View at Publisher · View at Google Scholar · View at Scopus
  156. A. Hall, “Rho GTPases and the control of cell behaviour,” Biochemical Society Transactions, vol. 33, no. 5, pp. 891–895, 2005. View at Publisher · View at Google Scholar · View at Scopus
  157. T. Rosenbaum, H. A. Kim, Y. L. Boissy, B. Ling, and N. Ratner, “Neurofibromin, the neurofibromatosis type 1 RaS-GAP, is required for appropriate P0 expression and myelination,” Annals of the New York Academy of Sciences, vol. 883, pp. 203–214, 1999. View at Scopus
  158. M. C. Harrisingh, E. Perez-Nadales, D. B. Parkinson, D. S. Malcolm, A. W. Mudge, and A. C. Lloyd, “The Ras/Raf/ERK signalling pathway drives Schwann cell dedifferentiation,” The EMBO Journal, vol. 23, no. 15, pp. 3061–3071, 2004. View at Publisher · View at Google Scholar · View at Scopus
  159. A. Woodhoo, M. B. D. Alonso, A. Droggiti et al., “Notch controls embryonic Schwann cell differentiation, postnatal myelination and adult plasticity,” Nature Neuroscience, vol. 12, no. 7, pp. 839–847, 2009. View at Publisher · View at Google Scholar · View at Scopus
  160. F. Ye, Y. Chen, T. Hoang et al., “HDAC1 and HDAC2 regulate oligodendrocyte differentiation by disrupting the β-catenin-TCF interaction,” Nature Neuroscience, vol. 12, no. 7, pp. 829–838, 2009. View at Publisher · View at Google Scholar · View at Scopus
  161. H. Li and W. D. Richardson, “Genetics meets epigenetics: HDACs and Wnt signaling in myelin development and regeneration,” Nature Neuroscience, vol. 12, no. 7, pp. 815–817, 2009. View at Publisher · View at Google Scholar · View at Scopus
  162. P. Topilko, S. Schneider-Maunoury, G. Levi et al., “Krox-20 controls myelination in the peripheral nervous system,” Nature, vol. 371, no. 6500, pp. 796–799, 1994. View at Publisher · View at Google Scholar · View at Scopus
  163. W.-M. Yu, M. L. Feltri, L. Wrabetz, S. Strickland, and Z.-L. Chen, “Schwann cell-specific ablation of laminin γ1 causes apoptosis and prevents proliferation,” Journal of Neuroscience, vol. 25, no. 18, pp. 4463–4472, 2005. View at Publisher · View at Google Scholar · View at Scopus
  164. D. B. Parkinson, A. Bhaskaran, A. Droggiti et al., “Krox-20 inhibits Jun-NH2-terminal kinase/c-Jun to control Schwann cell proliferation and death,” Journal of Cell Biology, vol. 164, no. 3, pp. 385–394, 2004. View at Publisher · View at Google Scholar · View at Scopus
  165. D. Ilić, C. H. Damsky, and T. Yamamoto, “Focal adhesion kinase: at the crossroads of signal transduction,” Journal of Cell Science, vol. 110, no. 4, pp. 401–407, 1997. View at Scopus
  166. M. Grove, N. H. Komiyama, K.-A. Nave, S. G. Grant, D. L. Sherman, and P. J. Brophy, “FAK is required for axonal sorting by Schwann cells,” Journal of Cell Biology, vol. 176, no. 3, pp. 277–282, 2007. View at Publisher · View at Google Scholar · View at Scopus
  167. T. Vartanian, A. Goodearl, S. Lefebvre, S.-K. Park, and G. Fischbach, “Neuregulin induces the rapid association of focal adhesion kinase with the erbB2-erbB3 receptor complex in Schwann cells,” Biochemical and Biophysical Research Communications, vol. 271, no. 2, pp. 414–417, 2000. View at Publisher · View at Google Scholar · View at Scopus
  168. A. Rettino, F. Rafaneli, G. Genovese, et al., “Identification of SP1 and GC-boxes as transcriptional regulators of mouse Dag-1 gene promoter,” American Journal of Physiology Cell Physiology, vol. 297, no. 5, pp. C1113–1123, 2009.
  169. P. Miura, J. V. Chakkalakal, L. Boudreault, et al., “Pharmacological activation of PPARβ/δ stimulates utrophin A expression in skeletal muscle fibers and restores sarcolemmal integrity in mature mdx mice,” Human Molecular Genetics, vol. 18, no. 23, pp. 4640–4649, 2009. View at Publisher · View at Google Scholar · View at Scopus
  170. B. E. Bernstein, A. Meissner, and E. S. Lander, “The mammalian epigenome,” Cell, vol. 128, no. 4, pp. 669–681, 2007. View at Publisher · View at Google Scholar · View at Scopus
  171. C. V. Melendez-Vasquez, J. C. Rios, G. Zanazzi, S. Lambert, A. Bretscher, and J. L. Salzer, “Nodes of Ranvier form in association with ezrin-radixin-moesin (ERM)-positive Schwann cell processes,” Proceedings of the National Academy of Sciences of the United States of America, vol. 98, no. 3, pp. 1235–1240, 2001. View at Publisher · View at Google Scholar · View at Scopus
  172. S. Etienne-Manneville, “Polarity proteins in glial cell functions,” Current Opinion in Neurobiology, vol. 18, no. 5, pp. 488–494, 2008. View at Publisher · View at Google Scholar · View at Scopus